AstraZenecaA brief overview

Pre-Pharmacy Society MeetingUniversity of DelawareRocco R. Duran R.Ph.Senior QA Executive – Global Quality Operations

2

Everyone cares about healthYoung or old. Rich or poor. Around the world. It’s one thingthat we all have in common

AstraZeneca is here to makea difference to people’s health

3

Doctors and patients

70 years of innovative medicines Touching the lives of many people

People who pay for healthcare

Our shareholders

The wider community

Our employees

4

Our focus is on six areas of medicine

Cancer

Cardiovascular disease

Infection

Gastrointestinal disease

Neurological disorders

Respiratory & inflammatory conditions

Top 8%Alongside our commitment to competitiveness and performance, we continue to be led by our core values to achieve sustainable success. We are positioned in the top 8% in the sector in the Dow Jones World and STOXX (European) Sustainability Indexes.

We employ over 61,000 people 47% in Europe, 30% in the Americas, 23% in Asia, Africa and Australasia

We invest over $4 billion in R&D each year and have over 15,500 people in our R&D organisation

In 2010, our worldwide sales totalled $33.3 billion).

|Pre-Pharmacy Society Meeting – November 10, 20116

Thank you for your time and interest

For more information about AstraZeneca and activities worldwide, visit astrazeneca.com